Advertisement
Screener

SIGHT SCIENCES, INC. (SGHT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.1 / 5 stars · 16/38 Roast Me

SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 61.67% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-03-04

  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-06-30 was 61.67%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 61.67%, a 22.65% decline year-over-year.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-09-30 was 79.82%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 79.73%.
  • SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 61.67%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2025-09-3061.67%
10-Q · filed 2025-11-06
2024-12-3161.67%
10-K · filed 2026-03-04
2024-09-3061.67%
10-Q · filed 2024-11-07
2024-06-3061.67%
10-Q · filed 2025-08-07
61.67%
10-Q · filed 2025-08-07
2024-03-3161.67%
10-Q · filed 2025-05-08
2023-09-3079.82%
10-Q · filed 2024-11-07
2023-03-3179.73%
10-Q · filed 2024-05-06
2020-09-3055.60%
10-Q · filed 2021-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
NeuroPace Inc (NPCE)United States$0.480B-28.52
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39